Imaging Biometrics, LLC (IB) develops ready-to-use software applications for the healthcare industry. The strength of Imaging Biometrics is its extensive software development experience integrated with its client-centric approach. Through close collaborations with top research minds in the medical imaging field, proprietary and sophisticated advancements are translated into easy and intuitive analytical software solutions for researchers and clinicians. These solutions are available as plug-ins for visualization software such as the highly acclaimed, open-source OsiriX and commercially-available products such as the aycan workstation.
IB Neuro™ automatically analyzes dynamically acquired MR datasets and generates parametric perfusion maps quantifying changes in contrast over time. Advancements in IB Neuro are designed to fit routine clinical and research workflow and address advanced clinical and research needs.
IB DCE™ software analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters. Employing the extended Tofts, Tofts and Patlak models, contrast agent permeability analysis is now intuitive and designed with the same user interface as other IB software products.
Diffusion-weighted imaging (DWI) is a powerful MRI method that probes abnormalities of tissue structure by detecting microscopic changes in water mobility at a cellular level beyond what is available with other imaging methods. Accordingly, DWI has the potential to identify pathology before gross anatomic changes are evident on standard anatomical brain images. These features of tissue characterization and earlier detection are what make DWI particularly appealing for the evaluation of gliomas and the newer therapies where standard anatomical imaging is proving insufficient. IB Diffusion™ analyzes MR diffusion-weighted images (DWI) and generates Apparent Diffusion Coefficient (ADC) maps, extrapolated b-value, intravoxel inherent motion (IVIM), and other diffusion parameters. b values can be read directly from DICOM image headers.
IB Delta Suite™ software analyzes conventional MR images and performs a variety of common and practical operations. For instance, pre– and post-contrast T1-wt. images can be co-registered, standardized, and subtracted to create Delta T1 (dT1) maps. dT1 maps are sensitive to subtle contrast enhancement on post-contrast T1-wt. images and selectively ignores blood products that enhance on pre-contrast T1-wt. images. Thus, dT1 maps aid in automatic detection of tumor regions free of blood products which is becoming increasingly useful in longitudinal analysis of patients treated with anti-angiogenic agents. In addition to separating blood products from tumor, dT1 maps enable easy, convenient visualization of post-surgical residual tumor.
IB Rad Tech™ is designed to allow users to customize and optimize preferred workflows using IB products. Once defined, IB Rad Tech can streamline the generation of sophisticated image maps, capture user-defined quality characteristics, and step the user through the workflow in an interactive, “wizard-like”, manner for repeatable and consistent processing of acquired datasets.
StoneChecker™ is an innovative medical software designed to aid clinical decision making by providing information about a patient’s kidney stone. The StoneChecker software tool is designed to be a streamlined semi-automated stone assessment tool that provides physicians with all the useful clinical metrics instantly using the patient’s non-contrast CT scans.